Intermountain Builds Up Bioinformatics to Make HerediGene Sequencing Data Clinically Actionable
The health system, which has now enrolled 150,000 people in its population genomics program, has implemented its technology across CDC tier one conditions but has grander ambitions.
23andMe Gains FDA Clearance for Simvastatin Pharmacogenetic Report
The new clearance removes the need for confirmatory testing to use 23andMe's SLCO1B1 report before prescribing simvastatin for hyperlipidemia.
Geisinger Researchers Win $7M for Familial Hypercholesterolemia Studies With Genetic Testing
The funding expands FH research at the health system and supports work using its MyCode community health initiative.
The startup has developed software to automate polygenic risk score generation for hospitals and labs using microarray or sequencing data.
Polygenic Variation Affects Disease Risk From Monogenic Variants, Study Finds
Accounting for polygenic background in conditions like hereditary breast cancer or Lynch syndrome can increase the accuracy of disease risk estimation.